Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Free Access

A Prospective Bicenter Study Investigating the Diagnostic Value of Procalcitonin in Patients with Acute Appendicitis

Sand M.a · Trullen X.V.c · Bechara F.G.b · Pala X.F.c · Sand D.d · Landgrafe G.a · Mann B.a

Author affiliations

aDepartment of General and Visceral Surgery, Augusta Krankenanstalt, Academic Teaching Hospital, and bDepartment of Dermatology and Allergy, University of Bochum, Bochum, Germany; cDepartment of General and Visceral Surgery, Hospital de Igualada, Consorci Sanitari de l’Anoia, Igualada, Spain; dDepartment of Physiological Science, University of California Los Angeles (UCLA), Los Angeles, Calif., USA

Corresponding Author

Michael Sand, MD

Department of General and Visceral Surgery

Augusta Krankenanstalt – Academic Teaching Hospital, Ruhr University Bochum

Bergstr. 26, DE–44791 Bochum (Germany)

Tel. +49 234 5170, Fax +49 234 517 2503, E-Mail michael.sand@ruhr-uni-bochum.de

Related Articles for ""

Eur Surg Res 2009;43:291–297

Do you have an account?

Login Information





Contact Information











I have read the Karger Terms and Conditions and agree.



Abstract

Background: Procalcitonin (PCT) is an established laboratory marker for disease severity in patients with infection and sepsis. In addition, PCT has been shown to be an effective marker for a limited number of localized infections. However, whether or not PCT has any diagnostic value for acute appendicitis, still remains unclear. The purpose of this prospective bicenter study was, therefore, to determine whether or not the PCT levels in the serum of patients with acute appendicitis have any diagnostic value. Methods: This prospective study included 103 patients who received an appendectomy, based on the clinical diagnosis of acute appendicitis, in a surgical department of an academic teaching hospital in Germany or in a county hospital in Spain. White blood cell count (WBC), C-reactive protein (CRP) and procalcitonin (PCT) values were determined preoperatively. All appendectomy specimens were sent for routine histopathological evaluation. Based on this information, the patients were assigned to 1 of 5 groups that reflected the severity of the appendicitis. Results: Of the 103 patients who were included in the study, 98 had appendicitis. Fourteen (14.3%) showed an increase in PCT values. Of those 14, 4 had a serum PCT >0.5 ng/ml, 9 had a PCT value >2–10 ng/ml and 1 had a PCT value >10 ng/ml. The sensitivity of PCT was calculated to be 0.14. The mean WBC value was 13.0/nl (± 5.2, 3.4–31), and for CRP it was 8.8 mg/dl (± 13, 0–60.2). The values of CRP, WBC and PCT increased with the severity of the appendicitis. Conclusions: PCT is potentially increased in rare cases of severe inflammation and, in particular, after appendiceal perforation or gangrenous appendicitis. However, its remarkably low sensitivity prohibits its routine use for the diagnosis of appendicitis.

© 2009 S. Karger AG, Basel


References

  1. Blomqvist PG, Andersson RE, Granath F, Lambe MP, Ekbom AR: Mortality after appendectomy in Sweden, 1987–1996. Ann Surg 2001;233:455–460.
  2. Schwarz A, Bolke E, Peiper M, Schulte am Esch J, Steinbach G, van Griensven M, et al: Inflammatory peritoneal reaction after perforated appendicitis: continuous peritoneal lavage versus nonlavage. Eur J Med Res 2007;12:200–205.
  3. Carrol ED, Thomson AP, Hart CA: Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002;20:1–9.
  4. Kafetzis DA, Velissariou IM, Nikolaides P, Sklavos M, Maktabi M, Spyridis G, et al: Procalcitonin as a predictor of severe appendicitis in children. Eur J Clin Microbiol Infect Dis 2005;24:484–487.
  5. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF, et al: Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396–404.
  6. Müller B, Becker KL: Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001;131:595–602.
    External Resources
  7. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600–607.
  8. Marc E, Ménager C, Moulin F, Stos B, Cha lumeau M, Guérin S, et al: Procalcitonin and viral meningitis: reduction of unnecessary antibiotics by measurement during an outbreak. Arch Pediatr 2002;9:358–364.
  9. Mueller C, Huber P, Laifer G, Mueller B, Perruchoud AP, et al: Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004;109:1707–1710.
  10. Oláh A, Belágyi T, Issekutz A, Makay R, Zaborszky A: Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis. Hepatogastroenterology 2005;52:243–245.
    External Resources
  11. Schwartz SL: Principles of Surgery, ed 5. New York, Mc Graw-Hill, 1989, appendix, chapt 29, pp 1315–1326.
  12. Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998;24:888–892.
  13. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515–518.
  14. Kisacik B, Kalyoncu U, Erol MF, Karadag O, Yildiz M, Akdogan A, et al: Accurate diagnosis of acute abdomen in FMF and acute appendicitis patients: how can we use procalcitonin? Clin Rheumatol 2007;26:2059–2062.
  15. Blab E, Kohlhuber U, Tillawi S, Schweitzer M, Stangl G, Ogris E, et al: Advancements in the diagnosis of acute appendicitis in children and adolescents. Eur J Pediatr Surg 2004;14:404–409.
  16. Kouame DB, Garrigue MA, Lardy H, Machet MC, Giraudeau B, Robert M: Is procalcitonin able to help in pediatric appendicitis diagnosis? Ann Chir 2005;130:169–174.
  17. Chakhunashvili L, Samkharadze J, Chkha idze I: Procalcitonin as the biomarker of inflammation in diagnostics of pediatric appendicitis and for prevention of unnecessary appendectomy. ABRE 2005;5:6–9.
  18. Sack U, Biereder B, Elouahidi T, Bauer K, Keller T, Tröbs RB: Diagnostic value of blood inflammatory markers for detection of acute appendicitis in children. BMC Surg 2006;6:15.
  19. Aslan A, Karaveli C, Ogunc D, Elpek O, Karaguzel G, Melikoglu M: Does noncomplicated acute appendicitis cause bacterial translocation? Pediatr Surg Int 2007;23:555–558.
  20. Wang G, An AP, Deng LF, et al: A study on virology of viral appendicitis in children. Abstracts 23rd Int Congr Paediatr, Beijing, September 2001.
  21. Grynspan D, Rabah R: Adenoviral appendicitis presenting clinically as acute appendicitis. Pediatr Dev Pathol 2008;11:138–141.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: March 02, 2009
Accepted: May 14, 2009
Published online: August 07, 2009
Issue release date: September 2009

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 3

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.